GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Medicine CHME · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$7,477

FY2025FY2025

Free cash flow

—

FY2025FY2025

Shareholders' equity

—

FY2025FY2025

Income statement

Fiscal years

FY2025
Operating income−$7,477
Net income−$7,477
Diluted earnings per share-0.00

Balance sheet

At each fiscal year end

FY2025
Shares outstanding73m

Cash flow

Fiscal years

Latest quarters

By quarter end

Jun 2026Mar 2026Sept 2010Jun 2010Mar 2010Dec 2009Sept 2009Jun 2009
Revenue——$17.6m$17.2m$10.6m$20.4m$19.2m$15.1m
Gross profit——$5.8m$6.1m$3.2m$6.8m$5.8m$3.5m
Operating income−$8,550−$2,953$2.5m$3.8m$1.2m$4.2m$4.5m$1.8m
Net income−$8,550−$2,953$2.2m$4.1m$1.8m−$2.1m$3.2m$41,996
Diluted earnings per share-0.00-0.000.060.100.05-0.140.210.00
Cash from operations———−$3.0m$1.0m$13.0m$1.0m$2.0m
Capital spending——−$4.0m———−$3.0m—
Free cash flow——————−$2.0m—
Total assets——$134.0m$135.1m$138.5m$66.8m$53.0m$46.7m
Cash and short-term investments——$7.9m$9.0m$11.1m$471,769$2.2m$1.8m
Debt——$3.2m$4.9m$11.4m$9.5m$2.9m—
Shareholders' equity——$77.6m$72.9m$60.4m$45.0m$46.4m$43.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income—-25.5%—
Net income—-25.5%—

Valuation history

At each fiscal year end

FY2025
Price to earnings-27.3

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return900%2900%-89%41600%2870%2789%515%12101%-25%872%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.